RepSox [446859-33-2]
Cat# HY-13012-50mg
Size : 50mg
Brand : MedChemExpress
| Description |
RepSox (E-616452) is a potent and selective transforming growth factor-beta receptor I/activin like kinase 5 (TGF-β-RI/ALK5) inhibitor. RepSox inhibits ALK5 autophosphorylation with an IC50 value of 4 nM. RepSox can be used for the research of obesity and associated metabolic diseases such as type 2 diabetes[1][2]. |
|||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IC50 & Target |
|
|||||||||||||||||||||||||
| Cellular Effect |
|
|||||||||||||||||||||||||
| In Vitro |
RepSox (compound 19) inhibits ALK5 autophosphorylation with an IC50 value of 4 nM[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot Analysis[2]
Immunofluorescence[2]
RT-PCR[2]
|
|||||||||||||||||||||||||
| Molecular Weight |
287.32 |
|||||||||||||||||||||||||
| Formula |
C17H13N5 |
|||||||||||||||||||||||||
| CAS No. | ||||||||||||||||||||||||||
| Appearance |
Solid |
|||||||||||||||||||||||||
| Color |
Light brown to yellow |
|||||||||||||||||||||||||
| SMILES |
CC1=NC(C2=NNC=C2C3=NC4=CC=CN=C4C=C3)=CC=C1 |
|||||||||||||||||||||||||
| Shipping | Room temperature in continental US; may vary elsewhere. |
|||||||||||||||||||||||||
| Storage |
|
|||||||||||||||||||||||||
| Solvent & Solubility |
In Vitro:
DMSO : 33.33 mg/mL (116.00 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles. Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
|
|||||||||||||||||||||||||
| Purity & Documentation | ||||||||||||||||||||||||||
| References |
|

